Skip to content
Interagency Autism Coordinating Committee (IACC)
Autism Research Database
Office of Autism Research Coordination (OARC)
 

Question 4: Long-term Objective C

yellow dot 4LC. Conduct at least one study to evaluate the safety and effectiveness of medications commonly used in the treatment of co-occurring conditions or specific behavioral issues in people with ASD by 2015. IACC Recommended Budget: $10,000,000 over 5 years.

Projects Found: 7
Total Funding: 665668
Project Title Funding Funding Institution

Project Title

Human Clinical Trial of IGF-1 in Children with Idiopathic ASD
$25,000

Funding

25000

Institution

Icahn School of Medicine at Mount Sinai

Project Title

1/4-RUPP Autism Network: Guanfacine for the treatment of hyperactivity in PDD
$1

Funding

1

Institution

Indiana University-Purdue University Indianapolis

Project Title

Mirtazapine treatment of anxiety in children and adolescents with pervasive developmental disorders
$99,971

Funding

99971

Institution

Indiana University

Project Title

2/4-RUPP Autism Network: Guanfacine for the treatment of hyperactivity in PDD
$171,791

Funding

171791

Institution

Seattle Children's Hospital

Project Title

3/4-RUPP Autism Network: Guanfacine for the treatment of hyperactivity in PDD
$200,372

Funding

200372

Institution

University of California, Los Angeles

Project Title

Metabolic signature of antipsychotics used in the treatment of autism
$0

Funding

0

Institution

University of Cincinnati

Project Title

4/4-RUPP Autism Network: Guanfacine for the treatment of hyperactivity in PDD
$168,533

Funding

168533

Institution

Yale University

 
Back to Top